Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 10:16 AM 2012  
BAX COV TMO BDX BCR CFN 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for IMUC

ImmunoCellul quote and profile

    
3.05
  
OTC EQUITY
 0.23   Macroaxis: 8.16 Up   8.16%  
 2.9 Trading Day  3.16 

Diversification Suggestion

Use ImmunoCellul for risky short term speculation or day-trading. The stock experiences very speculative upward sentiment. The trend is possibly hyped up

1 Month Beta ..........

0.8
As returns on market increase, ImmunoCellul returns are expected to increase less than the market. However during bear market, the loss on holding ImmunoCellul will be expected to be smaller as well.
ImmunoCellular Therapeutics Ltd. Small Beta
IMUC United States OTC BB
ImmunoCellular Therapeutics Ltd.
 
Trade ImmunoCellul
Current Valuation107.86 M
Shares Outstanding39.81 M
Cash and Equivalents13.56 M
One Year High3.4
 thisGreen IMUC IMUC.OB agains markets  8.16 % Macroaxis: change 8.16 Moved Up  
 
 United States NASDAQ   0.07 % Macroaxis: 0.07 Moved Down  
 
 United States SP 500   0.22 % Macroaxis: 0.22 Moved Down  
 
 United States NYSE   0.24 % Macroaxis: 0.24 Moved Down  
 

ImmunoCellul Leadership

MBA Singh CEO and President Director and Member of Fin. Committee
Manish Singh President CEO, Director, MBA
John MD Chairman, Chief Scientific Officer and Member of Products Strategy Committee
Rahul ScD Lead Director, Chairman of Fin. Committee, Member of Audit Committee, Member of Nominating and Corporate Governance Committee, Member of Compensation Committee and Member of Products Strategy Committee

ImmunoCellul Price and Market Media

The median price of ImmunoCellul for the period between Thu, Apr 26, 2012 and Sat, May 26, 2012 is 2.71 with a coefficient of variation of 7.42. The daily time series for the period is distributed with a sample standard deviation of 0.2, arithmetic mean of 2.69, and mean deviation of 0.16. The Stock did not receive any noticable media coverage during the period.
ImmunoCellul         Market
Price Growth (%)
 
Timeline

ImmunoCellul Summary

ImmunoCellular Therapeutics Ltd. [IMUC] is traded as part of a regulated electronic trading service offered by the NASD. The company currently falls under 'Small-Cap' category with current market capitalization of 121.42 M. ImmunoCellular Therapeutics Ltd. operates under Healthcare sector and is part of Medical Instruments and Supplies industry. This company has 39.81 M outstanding shares.

ImmunoCellul Liquidity

The company has Current Ratio of 9.71 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Discuss ImmunoCellul quote and profile

       
       
    
    
ImmunoCellul
Performance
5
Out Of
100
Over 30
Days
95% of all equities and portfolios perform better than ImmunoCellular Therapeutics Ltd.. Compared with the overall equity markets, risk-adjusted returns on investments in ImmunoCellular Therapeutics Ltd. are ranked lower than 5 (%) of all global equities and portfolios over the last 30 days.
    
    

Promote ImmunoCellul

    
Follow ImmunoCellul with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add ImmunoCellul to your reader
 
Get social with ImmunoCellul
 Get social with ImmunoCellul 
Share Toggle social options for ImmunoCellul
    

Add ImmunoCellul to Your Portfolio

    
Sign in to add this equity to your portfolios   
  
 
    

ImmunoCellul Research Report

    
    

ImmunoCellul Executives

Sanford JD Co-Founder and Secretary
David Fractor CFO, Treasurer, CPA

ImmunoCellul Directors

Helen Kim Independent Director, MBA
Rahul Singhvi Lead Independent Director, MBA
Richard Cowell Independent Director
Jacqueline Brandwynne Independent Director
Richard Chin Director



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting